Director/PDMR Shareholding
Summary by AI BETAClose X
Tristel plc
("Tristel" or the "Company")
Director/PDMR Shareholding
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that, on 11 December 2025, Tom Jenkins, Non Executive Director of the Company, purchased 5,400 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at a price of 368 pence per Ordinary Share.
As a result, Tom Jenkins' beneficial interest in the Company is now 13,400 Ordinary Shares, representing 0.03 per cent. of the total issued share capital.
For further information please contact:
|
Tristel plc |
Via Walbrook PR |
|||
|
Matt Sassone, Chief Executive Officer |
||||
|
Anna Wasyl, Chief Financial Officer |
|
|||
|
|
|
|||
|
Walbrook PR Ltd |
Tel: 020 7933 8780 or tristel@walbrookpr.com |
|||
|
Paul McManus / Lianne Applegarth / Anna Dunphy |
Mob: 07980 541 893/ 07584 391 303/ 07876 741 001 |
|||
|
|
|
|||
|
Cavendish Capital Markets Ltd |
Tel: 020 7220 0500 |
|||
|
Geoff Nash / Callum Davidson / Trisyia Jamaludin (Corporate Finance) |
|
|||
|
Sunila de Silva (Corporate Broking) / Louise Talbot (Sales) |
|
|||
About Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
For more information about Tristel's product range please visit: https://tristel.com
|
Details of the person discharging managerial responsibilities / person closely associated |
|
|
Name |
Tom Jenkins |
|
Reason for the Notification |
|
|
Position/status |
Director |
|
Initial notification/Amendment |
Initial notification |
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
Name |
Tristel plc |
|
LEI |
2138009DZ4LH9CZGF662 |
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
Description of the Financial instrument, type of instrument |
Ordinary shares of 1p each |
|
Identification code |
GB00B07RVT99 |
|
Nature of the transaction |
Purchase of Ordinary Shares |
|
Price(s) and volume(s) |
368 pence, 5,400 shares
|
|
Aggregated information: · Aggregated volume · Price |
See above
|
|
Date of the transaction |
11 December 2025 |
|
Place of the transaction |
London Stock Exchange, AIM Market (XLON)
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 hour ago Oxford Nanopore Technologies
- 2 hours ago AVI Global Trust
- 2 hours ago LSL Property Services
- 2 hours ago Bluebird Merchant Ventures (DI)
- 3 hours ago Power Probe PLC